These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1678365)

  • 41. Efficacy of Bacillus thuringiensis israelensis, Bacillus sphaericus and temephos for managing Anopheles larvae in Eritrea.
    Shililu JI; Tewolde GM; Brantly E; Githure JI; Mbogo CM; Beier JC; Fusco R; Novak RJ
    J Am Mosq Control Assoc; 2003 Sep; 19(3):251-8. PubMed ID: 14524547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of strain and medium variation on mosquito toxin production by Bacillus thuringiensis var. israelensis.
    Smith RA
    Can J Microbiol; 1982 Sep; 28(9):1089-92. PubMed ID: 7139413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-resistance to Bacillus sphaericus strains in Culex quinquefasciatus resistant to B. sphaericus 1593M.
    Poopathi S; Mani TR; Rao DR; Baskaran G; Kabilan L
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):477-81. PubMed ID: 10774654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Field evaluation of new water-dispersible granular formulations of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquitoes in microcosms.
    Su T; Mulla MS
    J Am Mosq Control Assoc; 1999 Sep; 15(3):356-65. PubMed ID: 10480128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Transgenic bioinsecticides inimical to parasites, but imical to environment].
    Kucińska J; Lonc E; Rydzanicz K
    Wiad Parazytol; 2003; 49(1):11-20. PubMed ID: 16889013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimization of medium composition for the production of mosquitocidal toxins from Bacillus thuringiensis subsp. israelensis.
    Poopathi S; Archana B
    Indian J Exp Biol; 2012 Jan; 50(1):65-71. PubMed ID: 22279944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Bacillus sphaericus and Bacillus thuringiensis var. israelensis for control of Culex pipiens and floodwater Aedes larvae in Iowa.
    Berry WJ; Novak MG; Khounlo S; Rowley WA; Melchior GL
    J Am Mosq Control Assoc; 1987 Dec; 3(4):579-82. PubMed ID: 3504943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immobilization in alginate as a technique for the preservation of Bacillus thuringiensis var. israelensis for long-term preservation.
    Prabakaran G; Hoti SL
    J Microbiol Methods; 2008 Jan; 72(1):91-4. PubMed ID: 18054810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clearance of Bacillus sphaericus and Bacillus thuringiensis ssp. israelensis from mammals.
    Siegel JP; Shadduck JA
    J Econ Entomol; 1990 Apr; 83(2):347-55. PubMed ID: 2345219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compatibility of Bacillus thuringiensis var. Israelensis and Bacillus sphaericus with the fungal pathogen Lagenidium giganteum (Oomycetes: Lagenidiales).
    Orduz S; Axtell RC
    J Am Mosq Control Assoc; 1991 Jun; 7(2):188-93. PubMed ID: 1895077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Large scale multiplication of Bacillus thuringiensis H. 14 asporogenic mutants & B. sphaericus strains for mosquito control.
    Balarman K; Bhatia MC; Tripathi SC; Hoti SL
    Indian J Med Res; 1987 Mar; 85():266-9. PubMed ID: 3610270
    [No Abstract]   [Full Text] [Related]  

  • 52. Entomopathogenic spore-formers from soil samples of mosquito habitats in northern Nigeria.
    Weiser J; Prasertphon S
    Zentralbl Mikrobiol; 1984; 139(1):49-55. PubMed ID: 6426190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity of mosquito-pathogenic bacterial strains to various antibodies.
    Gupta DK; Sharma RC; Bhatt RM; Gautam AS
    Indian J Exp Biol; 1992 Oct; 30(10):915-7. PubMed ID: 1363415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A carbon-limited medium for growth and sporulation of Bacillus thuringiensis var. kurstaki.
    Liu WM; Bihari V; Bajpai R
    Hindustan Antibiot Bull; 1995; 37(1-4):1-8. PubMed ID: 8972135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dark brown mutant of Bacillus thuringiensis H. 14 synthesising higher level of mosquito larvicidal factor.
    Balaraman K; Hoti SL
    Indian J Med Res; 1987 Mar; 85():270-3. PubMed ID: 2886429
    [No Abstract]   [Full Text] [Related]  

  • 56. A medium for the production of biopesticides (Bacillus sphaericus and Bacillus thuringiensis subsp. israelensis) in mosquito control.
    Poopathi S; Abidha S
    J Econ Entomol; 2009 Aug; 102(4):1423-30. PubMed ID: 19736752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of mosquito larvae by encapsulated pathogen Bacillus thuringiensis var. israelensis.
    Elçin YM
    J Microencapsul; 1995; 12(5):515-23. PubMed ID: 8544095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of amino nitrogen in the culture medium enhances the production of delta-endotoxin and biomass of Bacillus thuringiensis var. israelensis for the large-scale production of the mosquito control agent.
    Prabakaran G; Hoti SL
    J Ind Microbiol Biotechnol; 2008 Sep; 35(9):961-5. PubMed ID: 18509685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of the larvicidal activity of Bacillus thuringiensis serotype H14 on mosquitoes in natural breeding places].
    De Barjac H; Moulinier C; Couprie B; Giap G; Babin L; Mas JP
    Bull Soc Pathol Exot Filiales; 1980; 73(3):315-21. PubMed ID: 6112072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative sensitivities of six different species of mosquitoes to Bacillus thuringiensis var. israelensis].
    de Barjac H; Coz J
    Bull World Health Organ; 1979; 57(1):139-41. PubMed ID: 34488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.